Skip to content

A Pilot Study to Investigate Biomarkers in Anterior Cruciate Ligament (ACL) Patients and Healthy Controls

A Pilot Study to Investigate Biomarkers in ACL Patients and Healthy Controls

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02300012
Enrollment
8
Registered
2014-11-24
Start date
2015-01-05
Completion date
2022-05-20
Last updated
2022-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rupture of Anterior Cruciate Ligament

Keywords

Anterior cruciate ligament, Performance based investigations

Brief summary

Incident rates of ACL rupture are greatest in 16-39 year olds at almost 1 in 1,000. Performance Based Investigations (PBIs) can be used to evaluate and select correct approaches to patient treatment, and biochemical, biomechanical and physiological biomarkers in other conditions are sensitive in distinguishing between disease state severities, type of injuries and responsiveness to treatment. Despite the measurement sensitivity of PBIs, these are not widely used possibly owing to their focus postoperatively where benefits are less worthwhile. This study aims to investigate novel biomarkers as performance based investigations (PBIs) to improve surgical and treatment strategies in anterior cruciate ligament (ACL) patients. The objectives are to identify whether biomarkers, collected before and after operations, can: 1) Assist the surgeon in decision making; 2) Lead to improved prognosis; 3) Be used to predict the outcomes of prognosis, and; 4) Correlate with disease signs/ smoking to help further understand ACL injuries.

Interventions

PROCEDURESurgeons knowledge of pre-operative PBIs

Surgeon performing ACL repair will have prior knowledge of patients pre-operative PBIs to inform surgical practice

Sponsors

University of Lincoln
CollaboratorOTHER
United Lincolnshire Hospitals NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* unilateral ACL rupture * 18 - 45 years old

Exclusion criteria

* combined posterior and ACL rupture * multi-ligament instability including medial or lateral collateral ligament injury * other lower limb surgery \<3mths * current significant acute injury affecting other lower extremity joints, or other relevant neurological or musculoskeletal pathology.

Design outcomes

Primary

MeasureTime frame
The change in time taken to complete a sit-to-stand task, from baseline to 6 months post-ACL reconstructionBaseline, 6 months
The change in peak vertical ground reaction force from baseline to 6 weeks post-ACL reconstruction, measured when performing a novel isometric task during sitting.Baseline, 6 weeks
The change in peak vertical ground reaction force from baseline to 6 months post-ACL reconstruction, measured when performing a novel isometric task during sitting.Baseline, 6 months
The change in anterior-posterior centre of pressure displacement from baseline to 6 weeks post-ACL reconstruction, measured when performing a 10 second standing balance task.Baseline, 6 weeks
The change in anterior-posterior centre of pressure displacement from baseline to 6 months post-ACL reconstruction, measured when performing a 10 second standing balance task.Baseline, 6 months
The change in time taken to complete a sit-to-stand task, from baseline to 6 weeks post-ACL reconstructionBaseline, 6 weeks
The change in knee varus/valgus from baseline to 6 weeks post-ACL reconstruction, measured when performing a single leg squat.Baseline, 6 weeks
The change in knee varus/valgus from baseline to 6 months post-ACL reconstruction, measured when performing a single leg squatBaseline, 6 months

Secondary

MeasureTime frame
The change in Tegner Activity Score from baseline to 6 months post-ACL reconstruction6 months post-ACL reconstruction
The change in Lysholm Knee Scoring Scale from baseline to 6 months post-ACL reconstruction6 months post-ACL reconstruction
The change in International Knee Documentation Committee subjective knee evaluation form from baseline to 6 months post-ACL reconstructionbaseline to 6 months post-ACL reconstruction
The difference in bone morphogenetic protein-7 (BMP-7) between smokers and non-smokers who undergo ACL reconstructionAt time of surgery
The change in Interleukin-6 obtained from blood samples at baseline to 6 months post-ACL reconstruction6 months post-ACL reconstruction

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026